Full-Time

VP – Regulatory & Quality

Posted on 8/1/2025

Noah Medical

Noah Medical

201-500 employees

Medical robotics system for lung diagnostics

Compensation Overview

$240k - $295k/yr

+ Equity + Bonus

San Carlos, CA, USA

Hybrid

Hybrid within California; remote or onsite options may vary by team.

Category
Legal & Compliance (1)
Required Skills
Risk Management
Google Cloud Platform
Requirements
  • Bachelor's degree in a relevant scientific or engineering discipline; advanced degree preferred.
  • Extensive experience in regulatory affairs and quality management within the medical device, biotechnology, or related industries.
  • Proven track record of successful regulatory submissions, quality audits, and continuous improvement initiatives including clearance of multiple complex medical devices, i.e. devices that include capital hardware, disposable hardware, and software.
  • In-depth knowledge of regulatory requirements, standards, and guidelines (e.g., FDA, CFDA, EU MDR, EMA, ISO).
  • Strong understanding of quality management systems, including GMP, GCP, and ISO standards, e.g. 13485.
  • Excellent leadership, communication, and interpersonal skills.
  • Strategic mindset with the ability to drive change and foster innovation.
  • Thrives in a fast-paced, hands-on environment that is frequently changing.
  • Excellent written and verbal communication skills, with the ability to effectively communicate complex regulatory information to diverse audiences
  • Exceptional problem-solving and decision-making abilities.
  • Demonstrated experience in building, leading, and developing high-functional teams, with demonstrated success in fostering collaboration, innovation, and professional growth.
Responsibilities
  • Regulatory Compliance: Stay abreast of relevant regulatory requirements, guidelines, and industry best practices.
  • Develop and implement strategies to ensure compliance with local, national, and international regulations.
  • Advocate for the company\'s regulatory and quality interests and represent the organization in regulatory discussions, audits, inspections, and quality management reviews.
  • Ensure regulatory compliance by overseeing advertisement and promotional programs, including review and approval of marketing materials, advertising campaigns, and promotional activities in alignment with FDA regulations and international standards.
  • Quality Management Systems: Establish and maintain robust quality management systems (QMS) to support the organization's operations.
  • Lead the development, implementation, and maintenance of quality policies, procedures, and processes.
  • Monitor and evaluate the effectiveness of the QMS through audits, inspections, and metrics analysis.
  • Quality Assurance: Lead Design Control program to ensure that design inputs, verification, validation, and design transfer activities meet regulatory requirements and quality standards.
  • Develop and implement post-market surveillance strategies, including complaint handling, adverse event reporting, and corrective and preventive action (CAPA) processes, to ensure ongoing product safety and regulatory compliance.
  • Collaborate with cross-functional teams to address quality issues and drive corrective and preventive actions.
  • Risk Management: Identify and assess regulatory and quality risks associated with products, processes, and systems.
  • Develop and implement risk management strategies for hardware and software components, including risk assessment, mitigation plans, and risk-based decision-making processes to minimize compliance and quality-related risks.
  • Provide guidance on risk management principles and practices to relevant stakeholders.
  • Leadership and Team Management: Recruit, develop, and retain a high-performing team of regulatory and quality professionals.
  • Foster a culture of accountability, collaboration, and continuous improvement within the department.
  • Provide leadership, guidance, and mentorship to team members to support their professional growth and development.
  • Provide strategic regulatory/quality guidance to the leadership team in support of decision-making.
  • Provide strategic leadership in regulatory affairs and quality assurance, develop regulatory and quality strategies aligned with business objectives, and oversee the execution of regulatory and quality plans throughout the product lifecycle.
  • Cross-Functional Collaboration: Collaborate with other functional areas, including R&D, manufacturing, supply chain, and commercial teams, to integrate regulatory and quality considerations into product development and commercialization strategies.
  • Serve as a subject matter expert on regulatory and quality matters, providing guidance and support to cross-functional teams.
  • Continuous Improvement: Drive continuous improvement initiatives to enhance regulatory compliance and quality performance.
  • Champion quality excellence and promote a culture of quality throughout the organization.
  • Implement quality improvement tools and methodologies to streamline processes and optimize resource utilization.

NoahMed develops medical robotics systems for pulmonology, focusing on early diagnosis. Its flagship Galaxy System with TiLT+ Technology mitigates CT-to-body divergence to improve diagnostic yield and provides real-time navigation updates in all lung areas. It features an augmented fluoro overlay that guides locating non-visual lesions and a single-use bronchoscope with accessories to reduce cross-contamination and speed turnover, all in a compact, single-cart design for crowded operating rooms. The company differentiates itself through TiLT+ navigation, real-time augmented guidance, and a disposable—rather than reprocessed—bronchoscope setup, aiming to improve diagnostic confidence and efficiency. Its goal is to enhance early lung diagnosis with more reliable guidance, reducing procedure time and improving outcomes for patients in collaboration with interventional pulmonologists.

Company Size

201-500

Company Stage

Series B

Total Funding

$150M

Headquarters

Redwood City, California

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA clearance in March 2023 enabled first US use at University of Chicago.
  • $150M Series B led by SoftBank Vision Fund fuels Galaxy expansion.
  • 95% diagnostic accuracy in Cleveland Clinic's 100-patient study.

What critics are saying

  • Intuitive Surgical's Ion holds 80% market share, locking hospitals.
  • FDA safety notice on navigation errors halts Galaxy US expansion.
  • J&J's Ottava approval undercuts single-use accessory pricing by 25%.

What makes Noah Medical unique

  • Galaxy System™ uses TiLT+ Technology™ to overcome CT-to-body divergence.
  • Augmented fluoro overlays target lesions on live fluoro video.
  • Single-use bronchoscope prevents cross-contamination and speeds turnover.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Mental Health Support

Legal Services

Pet Insurance

12+ Paid Holidays

15-20 Days of PTO

Paid Parental Leave

In-office Snacks and Beverages

In-office Lunch Stipend

Learning & Development Opportunities

Team Building and Company Organized Social Events

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

3%
PR Newswire
Aug 6th, 2024
Memorialcare Cancer Institute At Saddleback Medical Center Offers Next Generation Robotic Bronchoscopy For Early Diagnosis And Treatment Of Lung Cancer

MemorialCare Cancer Institute uses first-of-its-kind robotic navigated bronchoscopy for greater precision and accuracy.LAGUNA HILLS, Calif., Aug. 6, 2024 /PRNewswire/ -- MemorialCare Cancer Institute's Lung Cancer Program at Saddleback Medical Center is one of just four hospitals in California equipped with the recently FDA-cleared robotic navigated bronchoscopy system. This new device from NoahMed, Galaxy System, uses integrated tomosynthesis (3D mammography) to navigate to and locate lung nodules, which are small masses in the lungs often tested for cancer.This improved visualization, along with a disposable bronchoscope, enhances precision and accuracy beyond the capabilities of existing technologies. It gives physicians access to often hard-to-reach lesions in the outer third of the lung which are often hard to biopsy. The Galaxy System can biopsy nodules smaller than 2cm, while receiving real-time lesion location updates."Lung cancer is an insidious disease causing far too high a toll on our communities," said Jayne Stewart, executive director, MemorialCare Cancer Institute, MemorialCare Saddleback Medical Center. "The Galaxy System gives physicians trained on the device a clear, direct path to improving patient diagnosis and, in turn, treatment –allowing us to catch lung cancer before it reaches less treatable, advanced stages

Yahoo Finance
May 30th, 2024
Noah Medical And Ceo Dr. Jian Zhang Named Finalists In Surgical Robotics Technology (Srt) Industry Awards

Noah MedicalNext-generation robotics company and its CEO recognized separately for pioneering work, innovative new technology, and rapid progressSAN CARLOS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that it has been named a finalist in the prestigious Surgical Robotics Industry Awards 2024 alongside its founder and CEO Dr. Jian Zhang. This joint recognition highlights Noah Medical’s groundbreaking work in endoluminal robotics and Dr. Zhang’s visionary leadership within the industry.Noah Medical is a finalist in the Innovative Start-up category, which honors companies under six years old that have demonstrated significant potential and introduced innovative solutions to enhance surgical procedures and patient outcomes. Dr. Zhang is a finalist in the Industry Leadership category, awarded to those who have demonstrated outstanding business or commercial success, highly effective management, and a track record as a thought leader.Since the beginning of 2023, Noah Medical has announced $150 million in Series B funding , secured FDA clearance for The Galaxy System™, its fully image-integrated solution for robotic navigated bronchoscopy, and launched the platform to commercial and industry acclaim.The company’s proprietary technology is transforming the early identification and diagnosis of lung cancer by making it possible for physicians to overcome traditional imaging and navigation limitations to confidently reach nodules in the outer periphery of the lung

The Robot Report
Jan 8th, 2024
2024 Surgical Robotics Outlook

Listen to this articleNoah Medical’s Galaxy is a fully integrated surgical robotics system for navigated bronchoscopy. | Credit: Noah Medical. Medical robotics continues its impressive march forward within mainstream medicine. From new applications to new technologies, the field demonstrated impressive growth over the last year. But there’s still incredible room to grow, and looking ahead to 2024, there are a few clear areas of opportunity

GlobeNewswire
Oct 19th, 2023
Noah Medical'S Galaxy System™ Named Finalist In 2023 Fierce Innovation Awards

SAN CARLOS, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that its Galaxy System, a fully image-integrated solution for robotic navigated bronchoscopy, was named a finalist in the 2023 Fierce Innovation Awards: Life Sciences Edition. The Galaxy System was recognized in the Medical Device Innovation category for its groundbreaking combination of innovative new technologies and features, including proprietary integrated tomosynthesis with augmented fluoroscope, a disposable single-use scope, and small footprint.Fierce Innovation Awards showcase innovations that have made an impact over the last 12 months and represent the greatest potential to transform the industry. The Galaxy System is the first of its kind and was built from the ground up based on physician feedback about the complex and life-altering decisions made during a lung biopsy procedure. With the introduction of the Galaxy System, more physicians in a broader range of clinical settings can diagnose disease earlier, ensuring patients can receive appropriate treatment at an earlier stage of the disease.“This award is a recognition of the entire team at Noah Medical, our commitment to revolutionizing medical robotics, and our work helping patients live better, healthier lives,” said Noah Medical CEO Jian Zhang. “We are honored to be praised by experts and peers within the industry for our work, we are transforming patient experiences and redefining the future of healthcare.”The Galaxy System’s “Tool-in-Lesion Tomography” or “TiLT” Technology was designed to overcome CT-to-body divergence by providing real-time lesion updates during a bronchoscopy procedure

The Robot Report
May 22nd, 2023
Noah Medical’S Galaxy System Is Used In The Us For The First Time

Noah Medical’s Galaxy System is used in the US for the first time. By Brianna Wessling | May 22, 2023Listen to this articleVIDEO. Noah Medical announced that its Galaxy System, an integrated system for navigated robotic bronchoscopy, was used for the first time in the United States at the University of Chicago Medicine by Dr. Kyle Hogarth.

INACTIVE